HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma (Q38422886)

3 September 2017

HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma (English)

1 reference

3 September 2017

Anthony Charles Nichols

object named as

Anthony C Nichols

1

0 references

William H. Westra

3

object named as

William H Westra

1 reference

3 September 2017

William C Faquin

2

1 reference

3 September 2017

Edmund A Mroz

4

1 reference

3 September 2017

Shanaz Begum

5

1 reference

3 September 2017

John R Clark

6

1 reference

3 September 2017

James W Rocco

7

1 reference

3 September 2017

1 February 2009

1 reference

Otolaryngology—Head and Neck Surgery

3 September 2017

1 reference

3 September 2017

140

1 reference

3 September 2017

2

1 reference

3 September 2017

228-234

1 reference

Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

Clinical implications of human papillomavirus in head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

Case-control study of human papillomavirus and oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

Cigarette smoking and cancer of the mouth, pharynx, and larynx. A continuing study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

p16(MTS-1/CDKN2/INK4a) in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

COOH-terminal binding protein regulates expression of the p16INK4A tumor suppressor and senescence in primary human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

Human papillomavirus and HPV vaccines: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2008.11.025

10.1016/J.OTOHNS.2008.11.025

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference